Sugi Predict

Sugi Predict / Compounds / SCHEMBL10259169

SCHEMBL10259169

SCHEMBL10259169

CCOP(=O)(OCC)C(C(=O)Nc1ccc2ccccc2c1OCC(=O)OC)c1cccc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CMA1 P23946 3/20 0.43
▸ HPGD P15428 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PTGER4 P35408 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CTSG P08311 1/20 0.35
▸ ACP3 P15309 1/20 0.35
▸ PTGS2 P35354 3/20 0.35
▸ LTC4S Q16873 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10259640 0.91 CMA1 (0.44) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL409832 0.88 CMA1 (0.55) CMA1PTGER4CYP1A2CYP2C19CTSG
SCHEMBL10259632 0.81 MAPT (0.38) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL13952863 0.78 CMA1 (0.50) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL10260383 0.78 CMA1 (0.50) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL10260984 0.78 CMA1 (0.47) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL10260988 0.77 CMA1 (0.49) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL10261983 0.77 CMA1 (0.49) CMA1HPGDALDH1A1THRBL3MBTL1
SCHEMBL8290033 0.77 CMA1 (0.53) CMA1PTGER4CTSGACP3
SCHEMBL13489658 0.77 CMA1 (0.48) CMA1HPGDALDH1A1THRBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546358-B2 Method of treating asthma JANSSEN PHARMACEUTICA NV (BE) 2013-10-01 — — US disclosed
US-20120022022-A1 NOVEL INHIBITORS OF CHYMASE HAWKINS MICHAEL J (US) 2012-01-26 — — US disclosed
US-20100048513-A1 Novel inhibitors of chymase HAWKINS MICHAEL J 2010-02-25 — — US disclosed
US-20100048513-A1 Novel inhibitors of chymase HAWKINS MICHAEL J 2010-02-25 — — US disclosed
US-20090036409-A1 Novel inhibitors of chymase HAWKINS MICHAEL J 2009-02-05 — — US disclosed
US-20090036409-A1 Novel inhibitors of chymase HAWKINS MICHAEL J 2009-02-05 — — US disclosed
US-7459444-B2 Inhibitors of chymase JANSSEN PHARMACEUTICA N.V. (BE) 2008-12-02 — — US disclosed
US-7459444-B2 Inhibitors of chymase JANSSEN PHARMACEUTICA N.V. (BE) 2008-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048513-A1 Novel inhibitors of chymase CMA1, SERPINB1, TPSAB1 CMA1 1/4885HPGD 849/4885ALDH1A1 1606/4885
US-20090036409-A1 Novel inhibitors of chymase CMA1, SERPINB1, TPSAB1 CMA1 1/4885HPGD 849/4885ALDH1A1 1606/4885
US-20120022022-A1 NOVEL INHIBITORS OF CHYMASE CMA1, SERPINB1, TPSAB1 CMA1 1/4885HPGD 849/4885ALDH1A1 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.